Home The effect of adenotonsilectomy on ghrelin, leptin, IGF-1 levels and growth parameters in children with adenotonsillar hypertrophy
Article
Licensed
Unlicensed Requires Authentication

The effect of adenotonsilectomy on ghrelin, leptin, IGF-1 levels and growth parameters in children with adenotonsillar hypertrophy

  • Nergis Salman EMAIL logo , Gulfer Ozturk , Istemihan Akin , Saffet Kilicaslan , Fatma Demirel and Namik Delibas
Published/Copyright: May 22, 2014
Journal of Pediatric Endocrinology and Metabolism
From the journal Journal of Pediatric Endocrinology and Metabolism Volume 27 Issue 9-10

Abstract

Aim: The purpose of this study was to search for the effects of adenotonsillectomy (A&T) on height, weight, and body mass index (BMI), as well as changes in ghrelin, leptin, and insulin-like growth factor 1 (IGF-1) levels in children with adenotonsillar hypertrophy (ATH)-related sleep-disordered breathing (SDB).

Methods: A study cohort of 39 children clinically diagnosed with ATH-related SDB was included in this study. Twenty-three healthy children were included as controls. Height and weight standard deviation scores (SDS) and ghrelin, leptin, and IGF-1 levels of the controls were determined once; in the study group, they were determined preoperatively and in the third month postoperatively.

Results: Preoperative IGF-1 (ng/mL) and ghrelin (pg/mL) levels were significantly higher in the patients than in the controls (322.51±113.10 vs. 256.96±176.73, p<0.05 and 106.08±9.75 vs. 80.11±28.50, p<0.001, respectively). The preoperative height and weight SDS values of the patients were lower than those of the controls (–0.67±1.36 vs. 0.13±1.13, p<0.05 and –0.38±1.35 vs. –0.20±1.29, respectively). The patients’ postoperative height and weight SDS values were significantly higher than their preoperative values (–0.05±1.08 vs. –0.67±1.36, p<0.0001 and 0.00±1.28 vs. –0.38±1.35, p<0.0001, respectively). The mean postoperative IGF-1 levels also were significantly higher than preoperative levels (386.05±130.06 vs. 322.51±113.10, p<0.05, respectively).

Conclusion: Plasma IGF-1 levels are lower in malnourished children, and plasma ghrelin levels are decreased after acute oral food intake and are increased in cachexia and fasting. Therefore, increased serum IGF-1 levels, height and weight SDS values, and decreased ghrelin levels detected postoperatively are useful parameters that help to monitor the development of children with adequate oral intakes.

Keywords: adenotonsillar hypertrophy; children; ghrelin; IGF-1; leptin
Corresponding author: Nergis Salman, MD, Department of Otorhinolaryngology, Ankara Children’s Hematology and Oncology Training and Research Hospital, 06110, Diskapi, Ankara/Turkey, Phone: +90 312 596 97 10, Fax: +90 312 347 23 30, E-mail:

References

1. Williams EF, Woo P, Miller R, Kellman RM. The effects of adenotonsillectomy on growth in young children. Otolaryngol Head Neck Surg 1991;104:509–16.10.1177/019459989110400415Search in Google Scholar

2. Bar A, Tarasiuk A, Segev Y, Phillip M, Tal A. The effect of adenotonsillectomy on serum insulin-like growth factor-I and growth in children with obstructive sleep apnea syndrome. J Pediatr 1999;135:76–80.10.1016/S0022-3476(99)70331-8Search in Google Scholar

3. Gozal D. Sleep-disordered breathing and school performance in children. Pediatrics 1998;102(3 Pt 1):616–20.10.1542/peds.102.3.616Search in Google Scholar

4. Shintani T, Asakura K, Kataura A. The effect of adenotonsillectomy in children with OSA. Int J Pediatr Otorhinolaryngol 1998;44:51–8.10.1016/S0165-5876(98)00047-0Search in Google Scholar

5. Bock A, Popp W, Herkner KR. Tonsillectomy and the immune system: a longterm follow up comparison between tonsillectomized and non-tonsillectomized children. Eur Arch Otorhinolaryngol 1994;251:423–7.10.1007/BF00181969Search in Google Scholar PubMed

6. Blum WF, Albertsson-Wikland K, Rosberg S, Ranke MB. Serum levels of insulin-like growth factor I (IGF-I) and IGF binding protein 3 reflect spontaneous growth hormone secretion. J Clin Endocrinol Metab 1993;76:1610–6.Search in Google Scholar

7. Yilmaz MD, Hosal AS, Oguz H, Yordam N, Kaya S. The effects of tonsillectomy on serum IGF-I and IGFBP3 levels in children. Laryngoscope 2002;112:922–5.10.1097/00005537-200205000-00026Search in Google Scholar PubMed

8. Selimoglu E, Selimoglu MA, Orbak Z. Does adenotonsillectomy improve growth in children with obstructive adenotonsillar hypertrophy? J Int Med Res 2003;31:84–7.10.1177/147323000303100204Search in Google Scholar PubMed

9. Ozen A, Furman A, Berber M, Karatepe HO, Mutlu N, et al. The effect of Helicobacter pyloriand economic status on growth parameters and leptin, ghrelin, and insulin-like growth factor (IGF)-I concentrations in children. Helicobacter 2011;16:55–65.10.1111/j.1523-5378.2010.00814.xSearch in Google Scholar PubMed

10. Van Der Lely AJ, Tschop M, Heiman ML, Ghigo E. Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr Rev 2004;25:426–57.10.1210/er.2002-0029Search in Google Scholar PubMed

11. Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, et al. A role for ghrelin in the central regulation of feeding. Nature 2001;409:194–8.10.1038/35051587Search in Google Scholar PubMed

12. Wasilewska J, Kaczmarski M, Debkowska K. Obstructive hypopnea and astroesophageal reflux as factors associated with residual obstructive sleep apnea syndrome. Int J Pediatr Otorhinolaryngol 2011;75:657–63.10.1016/j.ijporl.2011.02.004Search in Google Scholar

13. Kojima M, Kanagawa K. Ghrelin: structure and function. Physiol Rev 2005;85:495–522.10.1152/physrev.00012.2004Search in Google Scholar

14. Konturek SJ, Konturek JW, Pawlik T, Brzozowski T. Brain-gut axis and its role in the control of food intake. J Physiol Pharmacol 2004;55(1 Pt 2):137–54.Search in Google Scholar

15. Peters JH, McKay BM, Simasko SM, Ritter RC. Leptin-induced satiation mediated by abdominal vagal afferent. Am J Physiol Regul Integr Comp Physiol 2005;288:879–84.10.1152/ajpregu.00716.2004Search in Google Scholar

16. Ohlsson C, Bengstsson BA, Isaksson OG, Andreassen TT, Slootwag MC. Growth hormone and bone. Endocrinology 1998;19:55–79.Search in Google Scholar

17. Daughaday WH, Rotwein P, Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations. Endocrinology 1989;10:69–91.Search in Google Scholar

18. Bouhaddioui L, Brun JF, Jacquemin JL, Bailly A, Bouhaddioui N, et al. Immunoreactive somatomedin C in children from Morocco: a biological marker of nutritional growth retardation? Biomed Pharmacother 1989;43:59–63.10.1016/0753-3322(89)90192-3Search in Google Scholar

19. Beaune B, Blonc S, Fellmann N, Bedu M, Coudert J. Serum insulin-like growth factor I and physical performance in prepubertal Bolivian girls of a high and low socio-economic status. Eur J Appl Physiol 1996;76:98–102.10.1007/s004210050219Search in Google Scholar

20. Brodsky L, Moore L, Stanievich JF. A comparison of tonsillar size and oropharyngeal dimensions in childrenwith obstructive adenotonsillar hypertrophy. Int J Pediatr Otorhinolaryngol 1987;13:149–56.10.1016/0165-5876(87)90091-7Search in Google Scholar

21. Neyzi O, Furman A, Bundak R, Gunoz H, Darendeliler F, et al. Growth references for Turkish children aged 6 to 18 years. Acta Paediatr 2006;95:1635–41.10.1080/08035250600652013Search in Google Scholar PubMed

22. Guilleminault C, Stoohs R. Chronic snoring and obstructive sleep apnea syndrome in children. Lung 1990;168 (Suppl):912–9.10.1007/BF02718227Search in Google Scholar PubMed

23. Sen TA, Ayçiçek A. Do children with adenotonsillar hypertrophy have lower IGF-1 and ghrelin levels than the normal children? Int J Pediatr Otorhinolaryngol 2010;74:665–8.10.1016/j.ijporl.2010.03.016Search in Google Scholar PubMed

24. Ersoy B, Yuceturk AV, Taneli F, Urk V, Uyanik BS. Changes in growth pattern, body composition and biochemical markers of growth after adenotonsillectomy in prepubertal children. Int J Pediatr Otorhinolaryngol 2005;69:1175–81.10.1016/j.ijporl.2005.02.020Search in Google Scholar PubMed

25. Aydogan M, Toprak D, Hatun S, Yuksel A, Gokalp AS. The effect of recurrent tonsillitis and adenotonsillectomy on growth in childhood. Int J Pediatr Otorhinolaryngol 2007;71:1737–42.10.1016/j.ijporl.2007.07.012Search in Google Scholar PubMed

26. Kang JM, Auo HJ, Yoo YH, Cho JH, Kim BG. Changes in serum levels of IGF-1 and in growth following adenotonsillectomy in children. Int J Pediatr Otorhinolaryngol 2008;72:1065–9.10.1016/j.ijporl.2008.03.015Search in Google Scholar PubMed

27. Gumussoy M, Atmaca S, Bilgici B, Unal R. Changes in IGF-I, IGFBP-3 and ghrelin levels after adenotonsillectomy in children with sleep disordered breathing. Int J Pediatr Otorhinolaryngol 2009;73:1653–6.10.1016/j.ijporl.2009.08.025Search in Google Scholar PubMed

28. Nieminen P, Löppönen T, Tolonen U, Lannig P, Klip M, et al. Growth and biochemical markers of growth in children with snoring and obstructive sleep apnea. Pediatrics 2002;109:e55.10.1542/peds.109.4.e55Search in Google Scholar PubMed

29. Gnanapavan S, Kola B, Bustin SA, Morris DG, McGee P, et al. The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J Clin Endocrinol Metab 2002;87:2988–91.10.1210/jcem.87.6.8739Search in Google Scholar PubMed

30. Koc S, Ozturk K, Buyukbas S, Kocabas V, Ozer B, et al. Ghrelin levels in children with adenoid or chronic tonsil hypertrophies before and after surgery. Int J Pediatr Otorhinolaryngol 2009;73:685–7.10.1016/j.ijporl.2009.01.014Search in Google Scholar PubMed

31. Andiran N, Celik N, Ark N, Koca C, Kurtaran H, et al. Changes in growth pattern, leptin ghrelin and neuropeptide Y levels after adenotonsillectomy in prepubertal children. J Pediatr Endocrinol Metab 2013;26:683–7.10.1515/jpem-2012-0325Search in Google Scholar PubMed

32. Ceddia RB, Koistinen HA, Zierath JR, Sweeney G. Analysis of paradoxical observations on the association between leptin and insulin resistance. FASEB J 2002;16:1163–76.10.1096/fj.02-0158revSearch in Google Scholar PubMed

33. Kilic M, Taskin E, Ustundag B, Aygun AD. The evaluation of serum leptin level and other hormonal parameters in children with severe malnutrition. Clin Biochem 2004;37:382–7.10.1016/j.clinbiochem.2003.12.010Search in Google Scholar PubMed

34. Cummings DE, Overduin J. Gastrointestinal regulation of food intake. J Clin Invest 2007;117:13–23.10.1172/JCI30227Search in Google Scholar PubMed PubMed Central

35. Tschop M, Weyer C, Tataranni PA, Devanarayan V, Ravussin E, et al. Circulating ghrelin levels are decreased in human obesity. Diabetes 2001;50:707–9.10.2337/diabetes.50.4.707Search in Google Scholar PubMed

36. Yoshihara F, Kojima M, Hosoda H, Nakazato M, Kangawa K. Ghrelin: a novel peptide for growth hormone release and feeding regulation, Curr Opin Clin Nutr Metab Care 2002;5:391–5.10.1097/00075197-200207000-00007Search in Google Scholar PubMed

37. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K, Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999;402:656–60.10.1038/45230Search in Google Scholar PubMed

Received: 2013-9-11
Accepted: 2014-4-11
Published Online: 2014-5-22
Published in Print: 2014-9-20

©2014 by De Gruyter

Articles in the same Issue

  1. Frontmatter
  2. Review article
  3. Towards an optimization of the management of endocrine complications of thalassemia
  4. Original articles
  5. The natural course of Hashimoto’s thyroiditis in children and adolescents
  6. Muscle strength and body composition during the transition phase in patients treated with recombinant GH to final height
  7. Benign vaginal bleeding in 24 prepubertal patients: clinical, biochemical and imaging features
  8. Evaluation of epicardial adipose tissue, carotid intima-media thickness and ventricular functions in obese children and adolescents
  9. Counseling patients with succinate dehydrogenase subunit defects: genetics, preventive guidelines, and dealing with uncertainty
  10. Pubertal development profile in patients with Turner syndrome
  11. A novel CASR mutation associated with neonatal severe hyperparathyroidism transmitted as an autosomal recessive disorder
  12. Serum insulin-like growth factor-binding protein-3 level correlated with glycemic control and lipid profiles in children and adolescents with type 1 diabetes
  13. Adult human liver mesenchymal progenitor cells express phenylalanine hydroxylase
  14. Clinical applicability of rapid detection of SRY and DYS14 genes in patients with disorders of sex development using an indigenously developed 5′ exonuclease based assay
  15. Hereditary 1,25-dihydroxyvitamin D-resistant rickets with alopecia in four Egyptian families: report of three novel mutations in the vitamin D receptor gene
  16. Permanent neonatal diabetes mellitus in Jordan
  17. The effect of adenotonsilectomy on ghrelin, leptin, IGF-1 levels and growth parameters in children with adenotonsillar hypertrophy
  18. The role of anti-Mullerian and inhibin B hormones in the evaluation of 46,XY disorders of sex development
  19. The evaluation of thyroid carcinoma in childhood and concomitance of autoimmune thyroid disorders
  20. Lipid patterns in treated growth hormone deficient children vs. short stature controls
  21. Assessment of aortic morphology and compliance in children and adolescents with Ullrich-Turner syndrome (UTS) using magnetic resonance imaging (MRI)
  22. Management of central diabetes insipidus with oral desmopressin lyophilisate in infants
  23. Maternal factors and complications of preterm birth associated with neonatal thyroid stimulating hormone
  24. Patient reports
  25. A rare case of pituitary infarction leading to spontaneous tumour resolution and CSF-sella syndrome in an 11-year-old girl and a review of the paediatric literature
  26. Rare case of homozygous epimerase deficiency and heterozygous of duarte 2 variant
  27. Persistent congenital hyperinsulinism in two patients with Beckwith-Wiedemann syndrome due to mosaic uniparental disomy 11p
  28. Growth hormone treatment in a patient with Hurler-Scheie syndrome
  29. Neonatal diagnosis of a patient with hypoparathyroidism, sensorineural deafness and renal dysplasia (HDR) syndrome associated with cerebral infarction
  30. Early-onset diabetes mellitus and neurodevelopmental retardation: the first Greek case of Wolcott-Rallison syndrome
  31. Type III Bartter-like syndrome in an infant boy with Gitelman syndrome and autosomal dominant familial neurohypophyseal diabetes insipidus
  32. Cushing’s syndrome: hidden risk in usage of topical corticosteroids
  33. Prader-Willi syndrome: a case report with atypical developmental features
  34. Berardinelli-Seip congenital lipodystrophy: an autosomal recessive disorder with rare association of duodenocolonic polyps
  35. Ectopic Cushing syndrome secondary to metastatic medullary thyroid cancer in a child with multiple endocrine neoplasia syndrome type 2B: clues to early diagnosis of the paraneoplastic syndromes
  36. Ovarian hyperstimulation syndrome treated by medroxyprogesterone acetate
  37. Symptomatic cerebral infarction in a child with severe diabetic ketoacidosis
  38. A rare case of familial Cushing’s syndrome with a common presentation of weight gain due to a mutation of the PRKAR1A gene causing isolated primary pigmented nodular adrenocortical disease
  39. Multiple autoimmunity, type 1 diabetes (T1DM), autoimmune thyroiditis and thyroid cancer: is there an association? A case report and literature review
  40. Cholestasis and protein-losing enteropathy secondary to hyperthyroidism in a 6-year-old girl
  41. Short communication
  42. An essential splice site mutation (c.317+1G>A) in the TSHR gene leads to severe thyroid dysgenesis
  43. Letter to the Editor
  44. Pubertal gynecomastia: what about the remaining 10%?
https://doi.org/10.1515/jpem-2013-0367
Keywords for this article
adenotonsillar hypertrophy; children; ghrelin; IGF-1; leptin

Articles in the same Issue

  1. Frontmatter
  2. Review article
  3. Towards an optimization of the management of endocrine complications of thalassemia
  4. Original articles
  5. The natural course of Hashimoto’s thyroiditis in children and adolescents
  6. Muscle strength and body composition during the transition phase in patients treated with recombinant GH to final height
  7. Benign vaginal bleeding in 24 prepubertal patients: clinical, biochemical and imaging features
  8. Evaluation of epicardial adipose tissue, carotid intima-media thickness and ventricular functions in obese children and adolescents
  9. Counseling patients with succinate dehydrogenase subunit defects: genetics, preventive guidelines, and dealing with uncertainty
  10. Pubertal development profile in patients with Turner syndrome
  11. A novel CASR mutation associated with neonatal severe hyperparathyroidism transmitted as an autosomal recessive disorder
  12. Serum insulin-like growth factor-binding protein-3 level correlated with glycemic control and lipid profiles in children and adolescents with type 1 diabetes
  13. Adult human liver mesenchymal progenitor cells express phenylalanine hydroxylase
  14. Clinical applicability of rapid detection of SRY and DYS14 genes in patients with disorders of sex development using an indigenously developed 5′ exonuclease based assay
  15. Hereditary 1,25-dihydroxyvitamin D-resistant rickets with alopecia in four Egyptian families: report of three novel mutations in the vitamin D receptor gene
  16. Permanent neonatal diabetes mellitus in Jordan
  17. The effect of adenotonsilectomy on ghrelin, leptin, IGF-1 levels and growth parameters in children with adenotonsillar hypertrophy
  18. The role of anti-Mullerian and inhibin B hormones in the evaluation of 46,XY disorders of sex development
  19. The evaluation of thyroid carcinoma in childhood and concomitance of autoimmune thyroid disorders
  20. Lipid patterns in treated growth hormone deficient children vs. short stature controls
  21. Assessment of aortic morphology and compliance in children and adolescents with Ullrich-Turner syndrome (UTS) using magnetic resonance imaging (MRI)
  22. Management of central diabetes insipidus with oral desmopressin lyophilisate in infants
  23. Maternal factors and complications of preterm birth associated with neonatal thyroid stimulating hormone
  24. Patient reports
  25. A rare case of pituitary infarction leading to spontaneous tumour resolution and CSF-sella syndrome in an 11-year-old girl and a review of the paediatric literature
  26. Rare case of homozygous epimerase deficiency and heterozygous of duarte 2 variant
  27. Persistent congenital hyperinsulinism in two patients with Beckwith-Wiedemann syndrome due to mosaic uniparental disomy 11p
  28. Growth hormone treatment in a patient with Hurler-Scheie syndrome
  29. Neonatal diagnosis of a patient with hypoparathyroidism, sensorineural deafness and renal dysplasia (HDR) syndrome associated with cerebral infarction
  30. Early-onset diabetes mellitus and neurodevelopmental retardation: the first Greek case of Wolcott-Rallison syndrome
  31. Type III Bartter-like syndrome in an infant boy with Gitelman syndrome and autosomal dominant familial neurohypophyseal diabetes insipidus
  32. Cushing’s syndrome: hidden risk in usage of topical corticosteroids
  33. Prader-Willi syndrome: a case report with atypical developmental features
  34. Berardinelli-Seip congenital lipodystrophy: an autosomal recessive disorder with rare association of duodenocolonic polyps
  35. Ectopic Cushing syndrome secondary to metastatic medullary thyroid cancer in a child with multiple endocrine neoplasia syndrome type 2B: clues to early diagnosis of the paraneoplastic syndromes
  36. Ovarian hyperstimulation syndrome treated by medroxyprogesterone acetate
  37. Symptomatic cerebral infarction in a child with severe diabetic ketoacidosis
  38. A rare case of familial Cushing’s syndrome with a common presentation of weight gain due to a mutation of the PRKAR1A gene causing isolated primary pigmented nodular adrenocortical disease
  39. Multiple autoimmunity, type 1 diabetes (T1DM), autoimmune thyroiditis and thyroid cancer: is there an association? A case report and literature review
  40. Cholestasis and protein-losing enteropathy secondary to hyperthyroidism in a 6-year-old girl
  41. Short communication
  42. An essential splice site mutation (c.317+1G>A) in the TSHR gene leads to severe thyroid dysgenesis
  43. Letter to the Editor
  44. Pubertal gynecomastia: what about the remaining 10%?
Sign up now to receive a 20% welcome discount
Institutional Access
How does access work?
Have an idea on how to improve our website?
Please write us.
© 2025 De Gruyter Brill
Downloaded on 27.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2013-0367/html
Scroll to top button